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Abstract
Purpose: The purpose of this practice inquiry project was to evaluate provider adherence to
depression screening documentation in the ambulatory electronic health record (AEHR) before
and after changing locations of the depression screening questions within the AEHR. Provider
knowledge about depression screening and barriers related to depression screening were also
examined.
Methods: A retrospective chart review was completed for patients seen for an annual exam by a
physician provider in a women’s primary care clinic. Data collected included demographic data,
co-morbid conditions, depression screen documentation (PHQ-2 & PHQ-9), and interventions
documented. A questionnaire was sent to providers in the primary care clinic to assess
knowledge about depression and identification of barriers related to depressions screening.
Results: The retrospective chart review indicated that 2% of the patients were screened for
depression before the screening tool was moved in the AEHR, and 78% were screened after the
screening tool was moved. There were no significant differences in the two population samples.
Only one patient out of 50 was screened before the screening tool was moved, but 13 patients
were given prescriptions for medications for the treatment of depression. Provider knowledge of
the location of the screening tool has increased. Furthermore, time was identified as the greatest
barrier to screening for depression.
Conclusion: Depression screening improved after changing the AEHR placement of the
depression screening questions in the areas in which providers document prevention. “Yes”
responses from the patient on the PHQ-2 indicated a positive screen for depression, and these
positive responses on the PHQ-2 automatically directed the provider to the PHQ-9, a more
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extensive instrument for depression that measures symptom severity. Time was the most
significant barrier to screening for depression. Primary care providers may be the only
healthcare professional that are able to screen for depression since these providers are most
easily accessible to patients. Treating depression helps improve overall health, but can also
impact the management of other chronic diseases as well.
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Assessment of Depression Screening in Women’s Primary Care Clinic
The Centers for Disease Control and Prevention (CDC) (2011) report approximately
9.1% of the population currently meet the criteria for a diagnosis of depression. About twothirds of these people do not receive the help that they need (National Alliance on Mental Illness
[NAMI], 2009). In Kentucky, it is estimated that 22.2% of adults have suffered from major
depression at some time in their lives, and about 7.6% of Kentucky adults have suffered from
depression in the last 30 days (Kentucky Cabinet for Health and Family Services, 2004).
Depression can affect anyone at any age, but women are 70% more likely to experience
depression in their lifetime than men (National Institute of Mental Health [NIMH], 2014). It is
estimated that approximately one in eight women experience depression at some time during
their lifespan (NAMI, 2009). Women are more likely than men to have seasonal affective
disorder, have atypical symptoms of depression, to have comorbid anxiety disorders, and to
attempt suicide (Gorman, 2006).
Background
Depression is a mental illness that can be extremely debilitating and costly for individuals
(CDC, 2011). Symptoms associated with depression include: “sadness, anhedonia, pessimism,
feeling of emptiness, irritability, anxiety, worthlessness, thoughts of death or suicidal ideation,
disturbed sleep, change in appetite or weight, psychomotor changes, decreased energy, fatigue,
bodily aches and pains, impaired concentration, indecisiveness, and poor memory” (ChisholmBurns et al., 2013, p. 679). Depression can be attributed to a combination of genetic, biological,
environmental, and psychological factors, and it affects the individual’s ability to work, sleep,
study, eat, and enjoy life (NIMH, 2014). This mental illness is the leading cause of disability for
adults ages 15-44 in the United States (World Health Organization, 2008). Depression can cause
3

adults to experience “increased work absenteeism, short-term disability, and decreased
productivity” (CDC, 2011, p. 1). Approximately 80% of adults with depression state they have
some impairment in daily functioning because of their depression, and about 27% state that they
experience serious difficulties at work as well as at home (Pratt & Brody, 2008). It is estimated
that depression causes 200 million lost workdays each year which in turn costs employers $17 to
$44 billion (Leopold, 2001; Stewart, Ricci, Chee, Hahn, & Morganstein, 2003). Approximately
60% of the depressed patients are seen by primary care providers and these providers prescribe
79% of the total number of anti-depressant medications prescribed (Barkil-Oteo, 2013; Frank,
Huskamp, & Pincus, 2003). Therefore, screening in primary care is extremely important.
If depression is left untreated, it can lead to suicide (NIMH, 2014). In 2010, the suicide
rate for the United States was 12.43 per 100,000, while Kentucky’s rate was 14.2 per 100,000
(Suicide Prevention Resource Center, 2012). It is estimated that each day there are 42 attempted
suicides in Kentucky and two deaths from suicide (Suicide Prevention Resource Center, 2012).
Untreated depression associated with another chronic disease often produces worse
outcomes. Katon (2011) stated that “comorbid depression is associated with increased medical
symptom burden, functional impairment, medical costs, poor adherence to self-care regimens,
and increased risk of morbidity and mortality in patients with chronic medical disorders” (Katon,
2011, p. 1). People with a chronic medical condition, as well as depression, usually have more
severe symptoms of both conditions (NIMH, 2014). These individuals have more problems
adapting to medical conditions, and often incur higher costs associated with treatment when there
is a co-morbid diagnosis of depression (NIMH, 2014). Co-morbid conditions often associated
with depression include diabetes, coronary artery disease, stroke, cancer, chronic pain, thyroid
disorders, history of depression, and other mood or anxiety disorders (Mitchell et al., 2013).
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There are extremely high rates of depression associated with the co-morbid diagnoses of
coronary heart disease and diabetes (Katon, 2011). Depression can interfere with the patient’s
ability to engage in self-care of the chronic illness because it has an adverse effect on memory,
energy, and executive function (Katon, 2011). For these reasons, treating depression can
improve the treatment of other co-morbidities as patients may be more likely to adhere to the
treatment regimen (Whooley, 2012; Richardson & Puskar, 2012).
Screening for depression is important since the consequences can be irreversible such as
suicide and worsening of an individual’s health in relation to co-morbid conditions. The U.S.
Preventive Task Force Services (USPTFS) recommends that all adults, including pregnant and
postpartum women should be screened for depression (USPTFS, 2016). In accordance with this
recommendation, Healthy People 2020 has set a goal to increase the number of patients who are
screened for depression by primary care providers from 2.2% in 2007 to 2.4% by 2020
(USDHHS, 2012).
Few studies have been conducted to examine provider screening rates for depression in
primary care. It is extremely important to implement a systematic strategy for depression
screening to ensure the completion of screening (Klein, Ciotoli, & Chung, 2011). The Institute
for Clinical Systems Improvement’s (ICSI) guideline for depression in primary care recommends
first using the PHQ-2 instrument; in the event of a positive score (3 or greater), the PHQ-9
instrument should then be completed (Kroenke, Spitzer, & Williams, 2003; Mitchell et al.,
2013). Use of the PHQ-9 instrument is recommended in the primary care setting because it is
useful in indicating the severity of depression (Spritzer, Kroenke, & Williams, 1999).
In addition to screening, the providers must understand the risk factors associated with
depression to aid in understanding which patients may be at greater risk of developing depression
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(Mitchell et al., 2013). Some risk factors associated with depression are frequent visits to
primary care providers, patients with unexplained somatic complaints, history of depression,
family history of depression, chronic health conditions, other mental health disorders, and
refugee or immigrant status (Baas et al., 2009; Christensen, Sokolowski, & Olesen, 2011;
Maradiegue & Khan, 2013; Romera et al., 2013).
The healthcare system is changing as Medicare and Medicaid have instituted a Physician
Quality Reporting System (PQRS) (Koltov & Damle, 2014). This system is an incentive and
penalty program in which providers will no longer be paid a fee for their service, but rather paid
based on the quality of care delivered (Koltov & Damle, 2014). In the near future, the Centers
for Medicare and Medicaid Services (CMS) will begin to base reimbursements on these quality
indicators (CMS, 2013). One of the indicators is screening for clinical depression and
developing a follow-up plan (Measure # 134, NQF 0148) (CMS, 2013).
Providers may feel overwhelmed and have difficulty remembering all screenings that
must be completed. However, electronic health record provider prompts have been shown to
significantly increase screening for health conditions (Hsu et al., 2013; Van Cleave et al., 2012).
Devising a systematic way of screening and a protocol to follow is useful for implementing
screening and providing ease to providers who feel they are not sufficiently educated about
depression (Klein et al., 2011). Van Cleave et al. (2012) performed a systematic review
examining interventions to improve screening processes and follow up. Some of these studies
included electronic medical record templates and reminders which helped prompt providers to
screen. These electronic medical record enhancements as an intervention greatly improved
screening rates from baseline (Van Cleave et al., 2012).
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In the ambulatory electronic health record (AEHR) in a primary care clinic in a university
setting, depression screening was embedded in a category listed only as screening with a
checkbox to indicate completed. The depression screening questions were embedded in a detail
button which needed to be opened in order to complete the PHQ-2 questions. The full PHQ-9
screening tool was not available. CMS states that the PHQ questions must be answered
individually in order to meet the criteria for documentation of the quality indicator for
depression. The clinic manager, along with the informaticist, made the decision to move the two
questions of the PHQ-2 directly into the prevention area from the screening section of the AEHR
in January 2015 to better meet CMS requirements. The two PHQ-2 questions can be answered
with a check box, yes or no, and the full PHQ-9 questions are available when clicking on the
radio button. There is a text box to indicate the PHQ-9 score and further evaluation.
Purpose
The purpose of this Quality Improvement (QI) project was to evaluate depression
screening rates in a women’s primary care clinic by assessing documentation in the ambulatory
electronic health record (AEHR). The primary aim was to assess provider adherence to
depression screening during annual exams before and after the depression screening tool location
was changed in the AEHR. Before January 2015, the PHQ-2 screening tool was difficult to find
as it was embedded in the screening section in the annual exam form template in the AEHR and
required multiple steps in order to gain access to this screening tool. As of January 2015, the
PHQ-2 was moved to the prevention section of the AEHR and was more visible to providers.
The two PHQ-2 questions are part of the prevention section with the PHQ-9 questions under a
radial dial. The changes in location in the AEHR was discussed at a faculty meeting as well as
the CMS requirements for depression screening.
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This QI project was a retrospective medical record review completed to compare the rates
of depression screening completed by providers before and after moving the depression
screening tool in the AEHR. The secondary aim of this study was to assess provider knowledge
as well as barriers to completing depression screening. This was completed through the use of
an e-mail survey sent to the providers.
Methods
Design
A retrospective medical record review was completed in March 2016 to assess
documentation of depression screening during annual exams as well as interventions
recommended for depression by the PHQ-9 depression screening tool. Fifty records were
randomly selected for review during the four months before the PHQ screening tool was moved
(September 2014-December 2014) and 50 records were randomly selected for review during the
four months after the PHQ screening tool was relocated to the preventions section of the AEHR
(March 2015-June 2015). In addition, a provider survey was sent via e-mail to participating
providers to assess their knowledge of depression screening and the barriers to screening
patients.
Human Subject and Research Approval Procedures
Permission to conduct this QI project was granted by the University of Kentucky
Institutional Review Board (IRB). Patient consent was waived in compliance with IRB
regulations since data collection was completed through a retrospective medical record review in
which patient identifiers were not collected. Consent for the survey was implied by providers
completing the survey with all responses being confidential.
8

Study Population
This QI project was completed in a women’s health clinic within a university setting. A
total of 100 charts were randomly selected, 50 from the four months (September 2014-December
2014) before the depression screening instrument was moved and 50 from the four months
(February 2015-June 2015) after the instrument was relocated to the prevention section of the
AEHR. The inclusion criteria included female patients ages 18-89 who presented for an annual
physical exam in the clinic. Participating providers for the survey portion of the study included
the four physician providers at the clinic.
Data Collection
The Center for Clinical and Translational Science (CCTS) at the University of Kentucky
(UK) assembled a list of medical record numbers, patient names, physician provider,
appointment types of WELL40 or EP40, and appointment dates of patients that were seen
between September 2014 and December 2014 as well as between March 2015 and June 2015. A
list of 145 charts before moving the PHQ-2 and 185 charts after moving the PHQ-2 location
were obtained for the study. The charts were selected using a random number generator for each
of the two samplings of patients, 50 from before moving the PHQ-2 and 50 from after moving
the PHQ-2. Each of the selected charts were given an identification number that would be used
for collecting data during the medical record review to ensure no identifying information would
be collected on the patients.
Depression screening charted in the provider note was assessed for documentation of the
PHQ-2 being documented and the PHQ-9 being performed if the PHQ-2 was positive according
to the National Institute of Health and Clinical Excellence (NICE) guideline. The NICE
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guideline (2009) recommends that patients should be asked the following two questions (PHQ-2)
in order to screen for depression:
1. During the last month, have you often been bothered by feeling down, depressed, or
hopeless?
2. During the last month, have you often been bothered by having little interest or
pleasure in doing things? (p. 16)
Patients who answer ‘yes’ to either of these questions, should then be asked all the questions on
the PHQ-9 depression screening instrument to assess the risk and severity of depression (NICE,
2009). In addition to gathering this information, age, race, marital status, employment status,
insurance coverage, and common co-morbidities associated with a high risk of depression were
collected. Interventions such as no intervention, medication prescription, referral, and other
recommendations were also collected in this study.
All medical records were accessed in the clinic director’s secure clinic office on a
computer that was encrypted and password protected. The data collected for the medical record
review was documented and stored in REDCap, a secure online data collection tool provided by
the University of Kentucky. The data are securely hosted on Biomedical Informatics servers in
the secure data center operated by the Institute for Pharmaceutical Outcomes and Policy.
The provider survey was disseminated via REDCap in February 2016 and the four
providers were given three weeks to respond. All completed surveys were stored using
REDCap. The survey assessed provider’s knowledge about the location of the PHQ-2 in the
AEHR, screening practices, knowledge of the screening tool, and barriers to screening. The
management of depression, if it was diagnosed, was also evaluated.
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Data Analysis
Results from the retrospective medical record review were analyzed using the Statistical
Package for the Social sciences (SPSS) software. Descriptive statistics using frequencies were
used to assess age, race, employment status, marital status, insurance coverage, co-morbidities,
and the number of patients that were screened using the PHQ-2 tool. In addition, a chi-square
test of association and an independent samples t-test were used to ensure that the pre- and postpopulation samples were not significantly different. A chi-square test was run in order to
compare the proportion of records with depression screening documentation before and after
movement of the instrument to the prevention section of the AEHR. In order to determine
whether patient demographics such as age, race, marital status, employment status, type of
insurance, and co-morbid conditions were associated with whether a provider would screen for
depression, a chi-square test was also completed. Results were considered statistically
significant if the p-value was < 0.05. The survey results were descriptively evaluated by the
primary investigator since only three surveys were completed.
Results
Retrospective Ambulatory Electronic Health Record Review
The age range for the 100 charts reviewed was ages 19-76, with a mean of 44.38 (Table
1). Caucasian women made up 88% of the study sample while 11% were African American
women, and 1% were Asian women. Due to the numbers associated with different races, it was
recoded to state that Caucasians made up 88% of the sample and 12% were other races. Sixtyone percent of the study sample was married, 28% was single, and 11% were divorced. The
employment status of the sample consisted of 9% working part-time, 73% working full-time,
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16% not employed, and 2% did not have employment status documented. Insurance coverage
for the sample included 80% having HMO or PPO insurance, 11% having Medicaid insurance,
8% having Medicare insurance, and 1% not having insurance documented (Table 2).
There are many co-morbid conditions that can be associated with depression. The study
population consisted of 4% of the women diagnosed with diabetes, 2% had coronary artery
disease, 2% had a current diagnosis of cancer, while 6% had a history of cancer, 12% had
chronic pain, 30% had a history of depression, 26% had a thyroid disorder, and 19% had other
mood or anxiety disorders (Table 2).
The samples were examined overall, as well as individually, according to before and after
the relocation of the PHQ-2 and after the movement of the PHQ-2. When examining the
samples pre- and post-relocation, there was no significant difference between the two samples as
all p-values for age, race, marital status, employment status, insurance, and co-morbid conditions
were > 0.05 (Table 1 and Table 2).
Only 2% of the sample was screened for depression during the time period September
2014-December 2014 before the PHQ-2 screening tool was moved. From March 2015-June
2015, after the screening tool was moved, 78% of the patients were screened for depression
during their annual exam (Figure 1). This difference was significant when running Pearson’s
chi-square test of association as the p-value was <0.001 (Table 4).
Only one patient of the 40 patients screened answered yes to the PHQ-2 questions. The
PHQ-9 was documented for that patient. If the PHQ-2 is negative, then there is no reason to
complete the PHQ-9.
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When determining whether patient demographics, such as age, race, marital status,
employment status, insurance and co-morbid conditions, are associated with whether a provider
would screen for depression or not, there was no association between these factors. Pearson’s
chi-square test of association was completed on all the demographics and all p-values were >
0.05 (Table 5).
Interventions assessed when looking at the charts included no intervention, medication
prescribed, counseling referral, or other intervention not previously listed. No intervention
performed occurred 86% of the time overall, 78% of the time before the PHQ-2 tool was moved
and 94% of the time after the PHQ-2 instrument was moved. Medication was prescribed 13% of
the time overall, 20% of the time before the PHQ-2 tool was moved and 6% of the time after the
tool was moved. Counseling referral and other interventions only occurred once overall, during
the time before the PHQ-2 was moved (Table 6).
Provider Survey
Three out of four providers completed the survey, a 75% response rate. All of the
responses to the survey are summarized in Table 3. Of those who responded, only 1 stated that
she knew where the PHQ-2 depression screening instrument was located in the AEHR before it
was moved in January of 2015. All of the providers stated that they had at times screened for
depression and did not document the result before the screening tool was moved.
The three providers that responded all indicated that they knew the location of the
depression screening instrument in the prevention section after the relocation in January 2015.
Two out of the three providers stated that they continue to screen without documenting the
results. Two of the providers also stated that moving the screening tool has helped improve
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depression screening adherence. Only two out of the three providers indicated that if their
patient had a history of depression and the patient is there for follow-up, they use the PHQ2/PHQ-9 to see if the patient is improving with the treatment prescribed.
The only barrier that was reported related to screening for depression was time, and this
was the response of two of the providers. All three providers indicated that if the PHQ-2 score
was 2 or above, they were supposed to complete the PHQ-9. All three providers also specified
that they were aware that screening for depression is a PQRS measure and could soon involve
monetary penalties if it is not completed.
The treatment plan for a patient could involve different modalities. Three providers
indicate that they use medications, while none of the providers use hospitalization in their
treatment plan. All three providers use referral, and two of the providers include a wait and
reassess intervention. One provider indicated that she seeks immediate attention if there is
suicide ideation or homicide ideation present.
Discussion
Screening for depression is essential in diagnosing a patient and adequately treating this
mental disorder. Primary care providers are the most accessible to patients and should be
responsible for depression screening as many patients seek help from their primary care provider
for mental health issues because of the trust that they have in this provider (Zeidenstein, 2004).
Provider depression screening rates are not well-documented in the literature. However,
barriers related to depression screening consistently include time constraints (Baas et al., 2009;
Maradiegue & Khan, 2013; Romera et al., 2013). This QI project is consistent with reported

14

barriers to screening as two-thirds of the providers stated that time was a barrier encountered in
relation to depression screening.
The medical chart review indicated that 2% of the patients were screened for depression
before the screening questions were moved, which is less than the initial screening rate of 2.2%
according to the Healthy People 2020 (USDHHS, 2012). However, after the screening tool was
moved, the screening rate increased to 78%, which surpasses the Healthy People 2020 goal of
primary care providers screening for depression 2.4% of the time (USDHHS, 2012).
There is a lack of documentation in relation to depression screening (Romera et al.,
2013). This was supported by this QI project as providers stated that there are times they did
screen and did not document the PHQ-2 score.
One patient was screened for depression before the screening tool was moved. This
patient’s appointment was on December 8, 2014. The screening tool was moved on January 28,
2015, just a month later. During this time, the providers were receiving training regarding the
depression screen being moved and for this reason, it may have been fresh in their minds. For
this reason, it is possible that the training influenced the provider and caused this one patient to
be screened for depression when no others were screened before the instrument was moved in
the AEHR.
There was only one patient that screened positive for depression out of the 100 patient
charts reviewed. This number is less than the national average of 9.1% of people having
depression (CDC, 2011). This could be attributed to the sample seen at this particular clinic.
Most of the people in this clinic are employed and have PPO insurance through the university.
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Results from the study also indicated that providers were prescribing medications without
documented depression screening patients especially before the screening tool was moved. Only
one patient was screened during this period, but 13 patients received a prescription for a
medication that treats depression. The PHQ-9 could have been completed and documented to
evaluate whether or not medication changes were needed as recommended by ICSI (Mitchell et
al., 2013). Otherwise, there were no data to show why a patient is receiving that medication. In
the patients’ notes, the providers simply stated that the patient had depression and wrote the
prescription. There was no explanation of the patient doing well on the medication or reasons
for medication changes.
This study indicated that moving the depression screening instrument greatly increased
the rates of screening. Screening tools must be accessible to providers and easy to use. These
findings agree with previous studies where provider prompts in the EHR were shown to
significantly increase screening rates for different health conditions (Hsu et al., 2013; Van
Cleave et al., 2012). This allows providers to have reminders during busy and stressful clinic
settings.
Through completion of this study, some of the aspects included in the essentials of
doctoral education for advanced nursing practice were achieved. The first essential is Scientific
Underpinnings for Practice. This particular essential was met as this project used “sciencebased theories and concepts to describe actions and advanced strategies to enhance, alleviate, and
ameliorate health and health care delivery” as well as evaluating the outcomes (AACN, 2006, p.
9). The second essential is Organizational and Systems Leadership for Quality Improvement and
Systems Thinking. Essential two was met through this project as the primary investigator saw a
problem in the health care delivery system and worked to “promote patient safety and excellence
16

in practice” (AACN, 2006, p. 10). In addition, care delivery approaches were developed and
evaluated in order to meet the needs of the population while “ensur[ing] accountability for
quality of health care and patient safety for the population” (AACN, 2006, p. 10). The eighth
and final doctoral of nursing practice essential is Advanced Nursing Practice. This essential
includes that the professional will “design, implement, and evaluate therapeutic interventions
based on nursing science and other sciences.” (AACN, 2006, p. 16). This was completed
through this project as a new intervention for depression screening was designed, implemented,
and evaluated in order to improve depression screening in the clinic.
Limitations
One limitation of this study is the small sample size for both the medical record review as
well as the provider survey. However, despite the small sample size, documentation of
depression screening was significant when comparing documentation before and after moving
the location of the depression screening questions in the AEHR. The provider survey only had
three responses out of the four providers, and while this is a 75 percent response rate, it still is a
small sample size making it difficult to generalize findings to other clinical settings.
Another identifiable limitation is that the patient sample seen at this university setting is
unique. Many of the patients work at the university which could possibly skew the results
regarding the patient sample and diagnosis of depression. This particular sample population was
not diverse due to many patients being associated with the university and having university
insurance. Therefore, the results of this study may not be generalizable to other populations.
An additional limitation is that documentation of depression screening is completed by
providers who may have time constraints. For this reason, it could be that providers could have
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asked the PHQ-2 questions, but failed to document that they completed this screen. More
research is needed in relation to depression screening and screening rates in primary care clinics.
Implications for Practice
Interventions to encourage easy access for documentation can improve documentation of
depression screening as well as for other disease processes. Provider education related to
screening and monetary reimbursement-related expectations can also improve the documentation
of screening rates.
Screening allows providers to assess if a patient is depressed as well as the patient’s level
of depression. This determines whether treatment should be initiated or changed if a depression
diagnosis has previously been documented and are not at goal (NICE, 2009). The process is
quick, as initially the PHQ-2 consists of two yes or no questions. If the answer is yes to both
questions asked, then the provider can perform the PHQ-9 and get a comprehensive score that
indicates the severity of depression to aid in creating a treatment plan (Kroenke, Spitzer, &
Williams, 2003; Mitchell et al., 2013).
Screening for depression is especially important for patients with certain co-morbid
diseases as they frequently suffer from depression. These co-morbid conditions include diabetes,
coronary artery disease, stroke, cancer, chronic pain, thyroid disorders, history of depression, and
other mood or anxiety disorders (Mitchell et al., 2013).
Once a patient is diagnosed with depression, the PHQ-9 can be used to determine if the
prescribed treatment is effective and to indicate whether or not changes need to be made, such as
medication adjustments or referral for counseling (Mitchell et al., 2013). If a provider is going to
renew a prescription for medications to treat depression, the PHQ-9 should be completed in order
18

to provide information concerning the level of depression and guide the provider on continuing
the current dose or making changes to the dose. The importance of follow-up is extremely
important as the goal is to alleviate the symptoms the patient is experiencing, and if the patient
has a co-morbidity, the treatment of depression also helps improve the management of the other
disease (Mitchell et al., 2013; Richardson & Puskar, 2012; Whooley, 2012). Follow-up can
therefore help the patient in the many aspects of treating their medical conditions and improve
their overall health as a person. Documentation of the patient’s state of depression and response
to treatment is important for overall management. Treatment of depression also has a positive
impact on other serious health problems. Therefore, completion of the PHQ-9 is extremely
important in the management and treatment of a patient with depression.
Conclusion
Primary care providers are at the forefront in recognizing and treating depression. These
providers are in the optimal position to screen for and treat depression because many patients
prefer to remain in primary care because of the familiarity, location, patient-clinician
relationship, convenience, and reduced stigma related to diagnosis of a mental health illness
(Zeidenstein, 2004). If this disease process is not diagnosed in this setting, a patient may never
receive treatment. Therefore, it is imperative that primary care providers screen for depression.
This screening process may help in the treatment of many conditions because if depression is
found, it is possible that it is hindering the patient from adequately following the health plan for
other medical conditions. In this QI project, electronic prompts in the AEHR improved the
provider screening rates for depression by 76%. By providing reminders or increasing the ease
of documentation for clinicians, screening rates will increase allowing patients to receive the
treatment they need to improve their mental and overall health.
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Table 1. Population Sample Comparison of Continuous Variables
Overall Sample
(n=100)
Age Range
Age Mean
Standard
Deviation

19-76
44.38
12.960

Pre- movement
of PHQ-2
(n=50)
19-76
44.32
13.604

Post- movement
of PHQ-2
(n=50)
22-65
44.44
12.42

p-value

0.593

Table 2. Population Sample Comparison of Categorical Variables
Overall Pre- movement
Sample
of PHQ-2
(n=100)
(n=50)
Race
White
Other
Marital Status
Single
Married
Divorced
Employment Status
Part-Time
Full-Time
Not Employed
Not Documented
Insurance
HMO or PPO
Medicaid
Medicare
Not Documented
Co-morbid Conditions
Diabetes
CAD
Stroke
Cancer
History of Cancer
Chronic Pain
History of Depression
Thyroid Disorder
Other Mood or Anxiety Disorder

Post- movement
of PHQ-2
(n=50)

pvalue

88
12

47
3

41
9

0.065

28
61
11

13
30
7

15
31
4

0.613

9
73
16
2

6
36
7
1

3
37
9
1

80
11
8
1

39
5
5
1

41
6
3
0

4
2
0
2
6
12
30
26
19

3
0
0
1
3
6
17
16
12

1
2
0
1
3
6
13
10
7
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0.626

0.809

0.307
0.153
n/a
1.000
1.000
1.000
0.383
0.171
0.202

Table 3. Provider Survey Responses
Question
Did you know where the PHQ2 depressions screening
instrument was located in the
AEHR before it was moved on
January 28, 2015?
Were there times when you
screened for depression but
did not document the results
before January 28, 2015?
Do you currently know where
the PHQ-2 depression
screening instrument is
located?
Do you now sometimes screen
for depression without
documenting the score?
Has moving the location of the
PHQ-2 to the screening section
helped with your depression
screening adherence?
If your patient has a history of
depression and is there for
follow-up, do you use the
PHQ-2/PHQ-9 to see if they
are improving with the
treatment prescribed?
What are the barriers you
experience related to
screening for depression?
At what score with the PHQ-2
are you supposed to complete
a PHQ-9?
Are you aware that screening
for depression is a PQRS
measure and could soon
involve monetary penalties if it
is not completed?
What do you include in your
treatment plan when you
diagnose a patient with
depression? Please check all
that apply.

Response
Yes
No

N (out of 3)
1
2

Yes
No

3
0

Yes
No

3
0

Yes
No

2
1

Yes
No

2
1

Yes
No

2
1

Time
None

2
1

≥2
≥3
≥4
Yes
No

3
0
0
3
0

Medications
Hospitalization
Referral
Wait and Reassess
Seek immediate attention if SI/HI

3
0
3
2
1
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Table 4. Comparison of Screening before and after moving PHQ-2
Overall Sample
(n=100)
Depression
Screening

40

Pre- movement
of PHQ-2
(n=50)
1

Post- movement
of PHQ-2
(n=50)
39

p-value
<0.001

Table 5. Association Between Patient Demographics and Provider Screening
Patient Demographics
Age
Race
Marital Status
Employment Status
Type of Insurance
Diabetes Co-morbidity
CAD Co-morbidity
Stroke Co-morbidity
Cancer Co-morbidity
History of Cancer Co-morbidity
Chronic Pain Co-morbidity
Previous Diagnosis of Depression Co-morbidity
Thyroid Disorder Co-morbidity
Other Mood or Anxiety Disorder Co-morbidity

p-value
0.382
0.384
0.413
0.442
0.075
0.648
1.000
n/a
1.000
0.397
0.758
0.656
0.114
0.176

Table 6. Treatment Plan Interventions

None
Medication
Counseling Referral
Other

Overall Sample
n=100
86
13
1
1

Pre- movement of
PHQ-2 (n=50)
39
10
1
1

22

Post- movement of
PHQ-2 (n=50)
47
3
0
0

Depression Screening

49
39

11
1
SEPTEMBER 2014-DECEMBER 2014

MARCH 2015-JUNE 2015

PHQ-2 Completed

PHQ-2 Not Completed

Figure 1. Depression Screening Rates Before and After Moving the PHQ-2 instrument

Interventions
50
45
40
35
30
25
20
15
10
5
0
No Intervention

Medication

Counseling Referral

September 2014-December 2014

Other

March 2015-June 2015

Figure 2. Treatment Plan Interventions Before and After Moving the PHQ-2 Instrument
23

References
American Association of Colleges of Nursing (2006). The essentials of doctoral education
for advanced nursing practice. Retrieved from http://www.aacn.nche.edu/dnp/
Essentials.pdf
Baas, K. D., Wittkampf, K. A., van Weert, H. C., Lucassen, P., Huyser, J., van den Hoogen, H.,
… Schene, A. H. (2009). Screening for depression in high-risk groups: prospective
cohort study in general practice. The British Journal of Psychiatry, 194, 399-403. doi:
10.1192/bjp.bp.107.046052
Barkil-Oteo, A. (2013). Collaborative care for depression in primary care: How psychiatry could
“troubleshoot” current treatments and practices. The Yale Journal of Biology and
Medicine, 86(2), 139–146.
Centers for Disease Control and Prevention. (2011). An estimated 1 in 10 U.S. adults report
depression. Retrieved from http://www.cdc.gov/features/dsdepression/
Centers for Medicare and Medicaid Services (CMS). (2013). 2014 clinical quality measures
(CQMs) adult recommended core measures. Retrieved from http://www.cms.gov/
Regulations-and Guidance/Legislation/EHRIncentivePrograms/Downloads/2014_
CQM_AdultRecommend_CoreSetTable.pdf
Chisholm-Burns, M. A., Wells, B. G., Schwinghammer, T. L., Malone, P. M., Kolsar, J. M., &
Dipiro, J. T. (2013). Pharmacotherapy principles and practice (3rd ed.). New York,
NY: McGraw-Hill.
Christensen, K. S., Sokolowski, I., Olesen, F. (2011). Case-finding and risk-group screening for
depression in primary care. Scandinavian Journal of Primary Health Care, 29, 80-84.
doi: 10.3109/02813432.2011.554009

24

Frank, R. G., Huskamp, H. A., Pincus, H. A. (2003). Aligning incentives in the treatment of
depression in primary care with evidence-based practice. Psychiatric Services, 54(5),
682–687.
Gorman, J. (2006). Gender differences in depression and response to psychotropic medication.
Gender Medicine, 3(2), 93-109
Hsu, L., Bowlus, C. L., Stewart, S.L., Nguyen, T. T., Dang, J., Chan, B., & Chen, M. S. (2013).
Electronic messages increases hepatitis B screening in at-risk Asian American patients: A
randomized, controlled trial. Digestive Diseases and Sciences, 58(3), 807-814. doi:
10.1007/s10620-012-2396-9
Katon, W. J. (2011). Epidemiology and treatment of depression in patients with chronic medical
illness. Dialogues in Clinical Neuroscience, 13(1), 7-23.
Kentucky Cabinet for Health and Family Services (2004). Kentucky needs assessment project
brief report: Depression among Kentucky adults. Retrieved from http://cdar.uky.edu/
knap/Brief-Depress/KNAP-%20Depress%20Brief%20Report%20FINAL.pdf
Klein, M. C., Ciotoli, C., & Chung, H. (2011). Primary care screening of depression and
treatment engagement in a university health center: A retrospective analysis. Journal of
American College Health, 59(4), 289-295.
Koltov, M. K. & Damle, N. S. (2014). Health policy basics: Physician quality reporting system.
Annals of Internal Medicine, 161(5), 365-367. doi: 10.7326/M14-0786.
Kroenke, K., Spitzer, R., & Williams, J. (2003). The Patient Health Questionnaire-2: Validity of
a two-item depression screener. Medical Care, 41(11), 1284-1292.
Leopold, R. S. (2001). A year in the life of a million American workers. New York, New York:
MetLife Disability Group.

25

Maradiegue, A. H., & Khan, F. (2013). Missed opportunities in primary care: The importance of
identifying depression through screening, family history, and chronic disease
management. Journal of Psychosocial Nursing and Mental Health Services, 51(2), 2736.
Mitchell, J., Triangle, M., Degnan, B., Gabert, T., Haight, B., Kessler, D…Vincent, S. (2013).
Adult depression in primary care. Institute for Clinical Systems Improvement, 1-129.
Retrieved from https://www.icsi.org/_asset/fnhdm3/Depr-Interactive0512b.pdf
National Institute of Health and Clinical Excellence [NICE]. (2009). Depression in adults, the
treatment and management of depression in adults. Retrieved from
http://www.nice.org.uk/ guidance/cg90/chapter/guidance
National Alliance on Mental Illness [NAMI] (2009). Women and depression fact sheet.
Retrieved from http://www.networkofcare.org/library/womenanddepression.pdf
National Institute of Mental Health [NIMH] (2014). Depression. Retrieved from
http://www.nimh.nih.gov/health/topics/depression/index.shtml
Pratt, L., & Brody, D. (2008). Depression in the United States household population, 20052006. National Health and Nutrition Examination Survey. Retrieved from
http://www.cdc.gov/nchs/data/databriefs/db07.pdf
Richardson, L., & Puskar, K. (2012). Screening assessment for anxiety and depression in
primary care. The Journal for Nurse Practitioners, 8(6), 475-481.
Romera, I., Montejo, A. L., Aragones, E., Arbesu, J. A., Iglesias-Garcia, C., Lopez, S.,
…Gilaberte, I. (2013). Systematic depression screening in high-risk patients attending
primary care: a pragmatic cluster-randomized trial. BioMedical Central Psychiatry,
13(83), 1-9.

26

Spritzer, R. L., Kroenke, K., & Williams, J. B. (1999). Validation and utility of a self-report
version of PRIME-MD: The PHQ primary care study, primary care evaluation of mental
disorders. Journal of the American Medical Association, 282, 1737-1744.
Stewart, W. F., Ricci, J. A., Chee, E., Hahn, S. R., & Morganstein D. (2003). Cost of lost
productive work time among US workers with depression. JAMA, 289(23), 3135-3144.
Suicide Prevention Resource Center (2012). Facts at a glance – Suicide in Kentucky. Retrieved
from http://www.sprc.org/sites/sprc.org/files/event_materials/KY%201
7%20Fact%20Sheet.pdf
U.S. Department of Health and Human Services. (2012). Healthy people 2020 mental health and
mental disorders. Retrieved from http://www.healthypeople.gov/2020/topicsobjectives/topic/mental-health-and-mental-disorders/objectives
U.S. Preventive Services Task Force (USPSTF) (2016). Screening for depression in adults: US
Preventive Services Task Force Recommendation Statement. JAMA, 315(4), 380-387.
doi:10.1001/jama.2015.18392.
Van Cleave, J., Kuhlthau, K. A., Bloom, S., Newacheck, P. W., Nozzolillo, A. A., Homer, C. J.,
& Perrin, J. M. (2012). Interventions to improve screening and follow-up in primary
care: a systematic review of evidence. Academic Pediatrics, 12(4), 269-282. doi:
10.1016/j.acap.2012.02.004
Whooley, M. (2012). Diagnosis and treatment of depression in adults with comorbid conditions.
Journal of American Medical Association, 307, 1848-1857. doi:
10.1001/jama.2012.3466

27

World Health Organization. (2008). The global burden of disease 2004 update. Retrieved from
http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf?
ua=1
Zeidenstein, L. (2004). Health issues of lesbian and bisexual women. In Varney, H., Kriebs, J.
M., & Gegor, C. L. (Eds.). Varney’s Midwifery (pp. 299-311). Sudbury: Jones and
Bartlett Publishers.

28

